News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,834 Results
Type
Article (8025)
Company Profile (140)
Press Release (476572)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166760)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238245)
Policy (17922)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (264)
Approvals (10378)
Artificial intelligence (322)
ASCO (159)
Autoimmune disease (206)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (510)
Cancer (3653)
Cardiovascular disease (218)
Career advice (245)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47879)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (753)
Cystic fibrosis (85)
Data (5665)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (344)
Diagnostics (4187)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73716)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87627)
Executive appointments (702)
FDA (12400)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9318)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8659)
Medtech (8804)
Mergers & acquisitions (14385)
Metabolic disorders (709)
mRNA (56)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1828)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (203)
Partnered (12)
Patents (476)
Patient recruitment (509)
Peanut (31)
People (41243)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15470)
Phase 2 (21383)
Phase 3 (14405)
Pipeline (7351)
Policy (18)
Postmarket research (1570)
Preclinical (6539)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (575)
Real estate (3019)
Recruiting (6)
Regulatory (14834)
Reports (21)
Research institute (583)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (325)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (51)
Last 7 days (211)
Last 30 days (1596)
Last 365 days (19045)
2026 (12359)
2025 (19252)
2024 (22986)
2023 (26538)
2022 (34596)
2021 (37169)
2020 (33469)
2019 (23256)
2018 (17493)
2017 (18766)
2016 (17922)
2015 (24264)
2014 (21680)
2013 (18137)
2012 (20222)
2011 (20441)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17895)
Australia (2098)
California (11992)
Canada (3149)
China (524)
Colorado (485)
Connecticut (409)
Delaware (208)
Europe (24630)
Florida (1792)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (700)
India (51)
Indiana (314)
Iowa (15)
Japan (404)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1203)
Massachusetts (7863)
Michigan (308)
Minnesota (560)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2823)
North Carolina (1280)
North Dakota (4)
Northern California (6006)
Ohio (278)
Oklahoma (14)
Oregon (16)
Pennsylvania (2255)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4984)
Tennessee (120)
Texas (1943)
United States (38916)
Utah (361)
Vermont (1)
Virginia (153)
Washington D.C. (38)
Washington State (929)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,834 Results for "neuropace inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
FDA Grants De Novo Classification to neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes
April 7, 2026
·
5 min read
Press Releases
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026
April 27, 2026
·
6 min read
Press Releases
Neuropacs Announces the Publication of a New Study Comparing the First‑of‑Its‑Kind FDA De Novo–Classified Imaging Biomarker for Parkinson’s Disease with CSF Alpha‑Synuclein Seed Amplification Assay
June 2, 2026
·
5 min read
Press Releases
NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy
December 9, 2025
·
5 min read
Press Releases
NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
January 13, 2026
·
7 min read
Press Releases
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
October 23, 2025
·
1 min read
Press Releases
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
November 4, 2025
·
13 min read
Press Releases
NeuroPace Announces Strategic CFO Transition
June 25, 2025
·
5 min read
Press Releases
NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting
December 3, 2025
·
8 min read
Press Releases
NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
August 13, 2025
·
11 min read
1 of 48,484
Next
